To all interested Biotech investors, please feel free to discuss GENE
on this thread. I will put together financial information and additional
broker analysis on this stock as time progresses. My broker said that
the latest report from a firm that tracks this company projects a price
of $25 in 12 months, currently trading at $10 (5/16/96).
This company works on genome research to identify and characterize genes
involved in common diseases, and to translate the discoveries into therapeutic
breakthroughs.
GENE is a fast-growing and financially successful biotechnology company.
In the past year they have been awarded over US$10M by the NIH to develop
state-of-the-art DNA sequencing technology initiated a US$22M alliance with
Astra AB to develop genome-based drugs and vaccines entered into a US$40M
research collaboration with Schering-Plough Corporation to discover novel
anti-infective agents raised US$2.1M in a private capital placement and
raised US$44M in a public stock offering
Good Luck Tara!!! :) |
